{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:38:52Z","timestamp":1793770732712,"version":"4.6.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,7,24]],"date-time":"2015-07-24T00:00:00Z","timestamp":1437696000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s00774-015-0689-8","type":"journal-article","created":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T16:24:12Z","timestamp":1437668652000},"page":"540-546","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis"],"prefix":"10.1007","volume":"34","author":[{"given":"Nunziata","family":"Morabito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Gaudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Morini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Maria","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Tsiantouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Bellone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita Maria","family":"Agostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basilia","family":"Piraino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Angela","family":"La Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Salpietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Lasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,24]]},"reference":[{"key":"689_CR1","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1002\/jbmr.2266","volume":"29","author":"P Wong","year":"2014","unstructured":"Wong P, Fuller PJ, Gillespie MT, Kartsogiannis V, Kerr PG, Doery JC, Paul E, Bowden DK, Strauss BJ, Milat F (2014) Thalassemia bone disease: a 19\u00a0year longitudinal analysis. J Bone Miner Res 29:2468\u20132473","journal-title":"J Bone Miner Res"},{"key":"689_CR2","first-page":"773","volume":"11","author":"L Ruggiero","year":"1998","unstructured":"Ruggiero L, De Sanctis V (1998) Multicentre study on prevalence of fractures in transfusion-dependent thalassaemic patients. J Pediatr Endocrinol Metab 11:773\u2013778","journal-title":"J Pediatr Endocrinol Metab"},{"key":"689_CR3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/BF03344015","volume":"25","author":"A Lasco","year":"2002","unstructured":"Lasco A, Morabito N, Gaudio A, Crisafulli A, Meo A, Denuzzo G, Frisina N (2002) Osteoporosis and beta-thalassemia major: role of the IGF-I\/IGFBP-III axis. J Endocrinol Invest 25:338\u2013344","journal-title":"J Endocrinol Invest"},{"key":"689_CR4","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1359\/jbmr.040113","volume":"19","author":"N Morabito","year":"2004","unstructured":"Morabito N, Gaudio A, Lasco A, Atteritano M, Pizzoleo MA, Cincotta M, La Rosa M, Guarino R, Meo A, Frisina N (2004) Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle. J Bone Miner Res 19:722\u2013727","journal-title":"J Bone Miner Res"},{"key":"689_CR5","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1210\/jc.2002-021548","volume":"88","author":"P Mahachoklertwattana","year":"2003","unstructured":"Mahachoklertwattana P, Sirikulchayanonta V, Chuansumrit A, Karnsombat P, Choubtum L, Sriphrapradang A, Domrongkitchaiporn S, Sirisriro R, Rajatanavin R (2003) Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron-associated focal osteomalacia. J Clin Endocrinol Metab 88:3966\u20133972","journal-title":"J Clin Endocrinol Metab"},{"key":"689_CR6","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.bone.2007.02.020","volume":"40","author":"N Morabito","year":"2007","unstructured":"Morabito N, Russo GT, Gaudio A, Lasco A, Catalano A, Morini E, Franchina F, Maisano D, La Rosa M, Plota M, Crif\u00f2 A, Meo A, Frisina N (2007) The \u201clively\u201d cytokines network in beta-Thalassemia Major-related osteoporosis. Bone 40:1588\u20131594","journal-title":"Bone"},{"key":"689_CR7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s001980170079","volume":"12","author":"A Lasco","year":"2001","unstructured":"Lasco A, Morabito N, Gaudio A, Buemi M, Wasniewska M, Frisina N (2001) Effects of hormonal replacement therapy on bone metabolism in young adults with \u03b2-thalassemia major. Osteoporos Int 12:570\u2013575","journal-title":"Osteoporos Int"},{"key":"689_CR8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s001980200087","volume":"13","author":"N Morabito","year":"2002","unstructured":"Morabito N, Lasco A, Gaudio A, Crisafulli A, Di Pietro C, Meo A, Frisina N (2002) Bisphosphonates in the treatment of thalassemia-induced osteoporosis. Osteoporos Int 13:644\u2013649","journal-title":"Osteoporos Int"},{"key":"689_CR9","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s00774-014-0584-8","volume":"32","author":"A Giusti","year":"2014","unstructured":"Giusti A (2014) Bisphosphonates in the management of thalassemia-associated osteoporosis: a systematic review of randomised controlled trials. J Bone Miner Metab 32:606\u2013615","journal-title":"J Bone Miner Metab"},{"key":"689_CR10","first-page":"86","volume":"6","author":"E Voskaridou","year":"2008","unstructured":"Voskaridou E, Terpos E (2008) Pathogenesis and management of osteoporosis in thalassemia. Pediatr Endocrinol Rev 6:86\u201393","journal-title":"Pediatr Endocrinol Rev"},{"key":"689_CR11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00223-013-9749-z","volume":"93","author":"M Rossini","year":"2013","unstructured":"Rossini M, Gatti D, Adami S (2013) Involvement of WNT\/b-catenin signaling in the treatment of osteoporosis. Calcif Tissue Int 93:121\u2013132","journal-title":"Calcif Tissue Int"},{"key":"689_CR12","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2012-4039","volume":"98","author":"A Catalano","year":"2013","unstructured":"Catalano A, Morabito N, Basile G, Brancatelli S, Cucinotta D, Lasco A (2013) Zoledronic acid acutely increases sclerostin serum levels in women with postmenopausal osteoporosis. J Clin Endocrinol Metab 98:1911\u20131915","journal-title":"J Clin Endocrinol Metab"},{"key":"689_CR13","first-page":"725","volume":"94","author":"E Voskaridou","year":"2009","unstructured":"Voskaridou E, Christoulas D, Xirakia C, Varvagiannis K, Boutsikas G, Bilalis A, Kastritis E, Papatheodorou A, Terpos E (2009) Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration. Haematologica 94:725\u2013728","journal-title":"Reduction post-zoledronic acid administration. Haematologica"},{"key":"689_CR14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1055\/s-0032-1312618","volume":"44","author":"E Voskaridou","year":"2012","unstructured":"Voskaridou E, Christoulas D, Plata E, Bratengeier C, Anastasilakis AD, Komninaka V, Kaliontzi D, Gkotzamanidou M, Polyzos SA, Dimopoulou M, Terpos E (2012) High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density. Horm Metab Res 44:909\u2013913","journal-title":"Horm Metab Res"},{"key":"689_CR15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","volume":"350","author":"PJ Meunier","year":"2004","unstructured":"Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski J, Spector T, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459\u201346825","journal-title":"N Engl J Med"},{"key":"689_CR16","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2004-1774","volume":"90","author":"JY Reginster","year":"2005","unstructured":"Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C, Devogelaer JP, Curiel MD, Sawicki A, Goemaere S, Sorensen OH, Felsenberg D, Meunier PJ (2005) Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study. J Clin Endocrinol Metab 90:2816\u20132822","journal-title":"J Clin Endocrinol Metab"},{"key":"689_CR17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1210\/jc.2012-3048","volume":"98","author":"JM Kaufman","year":"2013","unstructured":"Kaufman JM, Audran M, Bianchi G, Braga V, Diaz-Curiel M, Francis RM, Goemaere S, Josse R, Palacios S, Ringe JD, Felsenberg D, Boonen S (2013) Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J Clin Endocrinol Metab 98:592\u2013601","journal-title":"J Clin Endocrinol Metab"},{"key":"689_CR18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/8756-3282(96)00080-4","volume":"18","author":"E Canalis","year":"1996","unstructured":"Canalis E, Hott M, Deloffre P, Tsouderos Y, Marie PJ (1996) The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone 18:517\u2013523","journal-title":"Bone"},{"key":"689_CR19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jbmr.5650080512","volume":"8","author":"PJ Marie","year":"1993","unstructured":"Marie PJ, Hott M, Modrowski D, De Pollak C, Guillemain J, Deloffre P, Tsouderos Y (1993) An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res 8:607\u2013615","journal-title":"J Bone Miner Res"},{"key":"689_CR20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s002230010055","volume":"69","author":"PJ Marie","year":"2001","unstructured":"Marie PJ, Ammann P, Boivin G, Rey C (2001) Mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int 69:121\u2013129","journal-title":"Calcif Tissue Int"},{"key":"689_CR21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bone.2007.08.043","volume":"42","author":"E Bonnelye","year":"2008","unstructured":"Bonnelye E, Chabadel A, Saltel F, Jurdic P (2008) Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone 42:129\u2013138","journal-title":"Bone"},{"key":"689_CR22","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00198-010-1369-0","volume":"22","author":"PJ Marie","year":"2011","unstructured":"Marie PJ, Felsenberg D, Brandi ML (2011) How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis. Osteoporos Int 22:1659\u20131667","journal-title":"Osteoporos Int"},{"key":"689_CR23","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s00774-013-0494-1","volume":"31","author":"JJ Stepan","year":"2013","unstructured":"Stepan JJ (2013) Strontium ranelate: in search for the mechanism of action. J Bone Miner Metab 31:606\u2013612","journal-title":"J Bone Miner Metab"},{"key":"689_CR24","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1359\/jbmr.070607","volume":"22","author":"P Ammann","year":"2007","unstructured":"Ammann P, Badoud I, Barraud S, Dayer R, Rizzoli R (2007) Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength. J Bone Miner Res 22:1419\u20131425","journal-title":"J Bone Miner Res"},{"key":"689_CR25","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00198-011-1847-z","volume":"23","author":"JY Reginster","year":"2012","unstructured":"Reginster JY, Kaufman JM, Goemaere S, Devogelaer JP, Benhamou CL, Felsenberg D, Diaz-Curiel M, Brandi ML, Badurski J, Wark J, Balogh A, Bruy\u00e8re O, Roux C (2012) Maintenance of antifracture efficacy over 10\u00a0years with strontium ranelate in postmenopausal osteoporosis. Osteoporos Int 23:1115\u20131122","journal-title":"Osteoporos Int"},{"key":"689_CR26","doi-asserted-by":"crossref","first-page":"23771","DOI":"10.1074\/jbc.M111.251116","volume":"286","author":"MS Rybchyn","year":"2011","unstructured":"Rybchyn MS, Slater M, Conigrave AD, Mason RS (2011) An Akt-dependent increase in canonical Wnt signaling and a decrease in sclerostin protein levels are involved in strontium ranelate-induced osteogenic effects in human osteoblasts. J Biol Chem 286:23771\u201323779","journal-title":"J Biol Chem"},{"key":"689_CR27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00404-008-0611-x","volume":"278","author":"I Gulhan","year":"2008","unstructured":"Gulhan I, Bilgili S, Gunaydin R, Gulhan S, Posaci C (2008) The effect of strontium ranelate on serum insulin like growth factor-1 and leptin levels in osteoporotic post-menopausal women: a prospective study. Arch Gynecol Obstet 278:437\u2013441","journal-title":"Arch Gynecol Obstet"},{"key":"689_CR28","unstructured":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser (1994) 843:1\u2013129"},{"key":"689_CR29","first-page":"191","volume":"10","author":"A Catalano","year":"2013","unstructured":"Catalano A, Morabito N, Basile G, Fusco S, Castagna G, Reitano F, Albanese RC, Lasco A (2013) Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina. Clin Cases Miner Bone Metab 10:191\u2013194","journal-title":"Clin Cases Miner Bone Metab"},{"key":"689_CR30","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s001980200129","volume":"13","author":"JY Reginster","year":"2002","unstructured":"Reginster JY, Deroisy R, Dougados M, Jupsin I, Colette J, Roux C (2002) Prevention of early postmenopausal bone loss by strontium ranelate: the randomised, 2\u00a0year, double masked, dose-ranging, placebo-controlled PREVOS study. Osteoporos Int 13:925\u2013931","journal-title":"Osteoporos Int"},{"key":"689_CR31","first-page":"2060","volume":"87","author":"PJ Meunier","year":"2002","unstructured":"Meunier PJ, Slosman DO, Delmas PD, Sebert JL, Brandi ML, Albanese C, Lorenc R, Pors-Neilsen S, de Vernejoul MC, Roces A, Reginster JY (2002) Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis\u2013a 2\u00a0year randomised placebo controlled trial. J Clin Endocrinol Metab 87:2060\u20132066","journal-title":"J Clin Endocrinol Metab"},{"key":"689_CR32","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1210\/jc.2006-2758","volume":"92","author":"O Bruyere","year":"2007","unstructured":"Bruyere O, Roux C, Detilleux J, Slosman DO, Spector TD, Fardellone P, Brixen K, Devogelaer JP, Diaz-Curiel M, Albanese C, Kaufman JM, Pors-Nielsen S, Reginster JY (2007) Relation between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate. J Clin Endocrinol Metab 92:3076\u20133081","journal-title":"J Clin Endocrinol Metab"},{"key":"689_CR33","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1007\/s00198-011-1871-z","volume":"23","author":"M Doyard","year":"2012","unstructured":"Doyard M, Fatih N, Monnier A, Island ML, Aubry M, Leroyer P, Bouvet R, Chal\u00e8s G, Mosser J, Lor\u00e9al O, Guggenbuhl P (2012) Iron excess limits HHIPL-2 gene expression and decreases osteoblastic activity in human MG-63 cells. Osteoporos Int 23:2435\u20132445","journal-title":"Osteoporos Int"},{"key":"689_CR34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00198-011-1547-8","volume":"23","author":"ET Middleton","year":"2012","unstructured":"Middleton ET, Steel SA, Aye M, Doherty SM (2012) The effect of prior bisphosphonate therapy on the subsequent therapeutic effects of strontium ranelate over 2 years. Osteoporos Int 23:295\u2013303","journal-title":"Osteoporos Int"},{"key":"689_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-015-0299-2","author":"A Catalano","year":"2015","unstructured":"Catalano A, Morabito N, Di Stefano A, Morini M, Basile G, Faraci B, Loddo S, Ientile R, Lasco A (2015) Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate. JENI. doi: 10.1007\/s40618-015-0299-2","journal-title":"JENI"},{"key":"689_CR36","unstructured":"European medicines agency. Press release: European medicines agency recommends that protelos\/osseor remain available but with further restrictions (2014) http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2014\/02\/news_detail_002031 . jsp&mid\u00a0=\u00a0WC0b01ac58001d126"},{"key":"689_CR37","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00198-007-0464-3","volume":"19","author":"P Marquis","year":"2008","unstructured":"Marquis P, Roux C, de la Loge C, Diaz-Curiel M, Cormier C, Isaia G, Badurski J, Wark J, Meunier PJ (2008) Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis. Osteoporos Int 19:503\u2013510","journal-title":"Osteoporos Int"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-015-0689-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-015-0689-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-015-0689-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:16:57Z","timestamp":1559110617000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-015-0689-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,24]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["689"],"URL":"https:\/\/doi.org\/10.1007\/s00774-015-0689-8","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,24]]}}}